Instrumentation gets together with Optical Sensors:
This article was originally published in Clinica
Executive Summary
The Italian company Instrumentation Laboratory and Optical Sensors of the US have agreed a seven-year partnership to distribute the Gem SensiCath and Gem OpticalCAM hospital point-of-care diagnostic products and their established line of critical care products. According to the companies, the non-glucose meter POC market was worth $300 million in 1996 and is set to reach $800 million by 2001. The arrangement with Instrumentation does not affect Optical's current arrangements with Hewlett-Packard, Marquette and SpaceLabs, which will continue to sell SensiCath arterial blood gas monitoring.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.